Advancements in Gynecology: A Weekly Review
Ginecologia e Ostetricia
Ethics and Innovations in Reproductive Health Advances
This week’s episode offers a sharp look at how medical progress can clash with ethical realities. From forced sterilizations still happening in 2025, to breakthroughs in treating adenomyosis-related infertility and ovarian cancer, we highlight the latest studies shaping reproductive healthcare. We also explore new data on surgical risks, contraception safety, and advances in fetal monitoring driven by AI. A concise, evidence-based roundup that questions assumptions and pushes toward more ethical, patient-centered care.
Bibliography
- Maila SM et al. Informed consent and ethical issues in female sterilization: a scoping review. Int J Gynaecol Obstet. 2025;169(3):1037–64.
- Yang R et al. Placenta accreta risk after non-cesarean uterine surgery: systematic review and meta-analysis. Obstet Gynecol. 2025;145(6):628–38.
- Shen K et al. Antibody-drug conjugates for platinum-resistant ovarian cancer: mono and combo therapy. Oncol Rep. 2025;53(6):68.
- Lovers A et al. Fetal heart rate monitoring: strategic updates and innovations. BJOG. 2025;132(7):853–66.
- Creinin MD et al. Estetrol/Drospirenone safety in women with cardiovascular risk. Contraception. 2025;146:110861.
- Kwak-Kim J et al. Risks of immunomodulatory compounds on pregnancy. J Reprod Immunol. 2025;169:104453.
- Kwon JS et al. Tailored care in oncofertility and oncomenopause: is less more? ASCO Educ Book. 2025;45(3):e481126.
